5 June 2012 Improved tumor contrast achieved by single time point dual-reporter fluorescence imaging
Author Affiliations +
J. of Biomedical Optics, 17(6), 066001 (2012). doi:10.1117/1.JBO.17.6.066001
Abstract
In this study, we demonstrate a method to quantify biomarker expression that uses an exogenous dual-reporter imaging approach to improve tumor signal detection. The uptake of two fluorophores, one nonspecific and one targeted to the epidermal growth factor receptor (EGFR), were imaged at 1 h in three types of xenograft tumors spanning a range of EGFR expression levels (n = 6 in each group). Using this dual-reporter imaging methodology, tumor contrast-to-noise ratio was amplified by <6 times at 1 h postinjection and <2 times at 24 h. Furthermore, by as early as 20 min postinjection, the dual-reporter imaging signal in the tumor correlated significantly with a validated marker of receptor density (P<0.05, r = 0.93). Dual-reporter imaging can improve sensitivity and specificity over conventional fluorescence imaging in applications such as fluorescence-guided surgery and directly approximates the receptor status of the tumor, a measure that could be used to inform choices of biological therapies.
Kenneth M. Tichauer, Kimberley S. Samkoe, Kristian J. Sexton, Jason R. Gunn, Tayyaba Hasan, Brian W. Pogue, "Improved tumor contrast achieved by single time point dual-reporter fluorescence imaging," Journal of Biomedical Optics 17(6), 066001 (5 June 2012). http://dx.doi.org/10.1117/1.JBO.17.6.066001
Submission: Received ; Accepted
JOURNAL ARTICLE
11 PAGES


SHARE
KEYWORDS
Tumors

Luminescence

Receptors

Tissues

Surgery

Kidney

Blood

Back to Top